| Chemical & Physical Properties | |
|---|---|
| CAS Number | 201595-70-2 |
| Catalog No. | 2A-1195227 |
| Chinese Name | L-乳酸钠-3-13C |
| Synonyms | MFCD00084067 |
| Molecular Formula | 13CH3CH(OH)CO2Na |
| Molecular Weight | 113.05 |
| Purity | ≥98 (CP) |
| Melting Point | 163-165ºC(lit.) |
| Storage Condition | Store airtight in a cool, dry warehouse. |
| Application | Lactate-13C-1 (sodium) is 13C-labeled lactate (sodium) [1]. Sodium lactate is a product of glycogenolysis and glycolysis. Sodium lactate plays a role in various biochemical processes [2]. |
| PubChem ID | 24872519 |
| MDL Number | MFCD00084067 |
| SMILES | [Na+].[13CH3][C@H](O)C([O-])=O |
| InChI | 1S/C3H6O3.Na/c1-2(4)3(5)6;/h2,4H,1H3,(H,5,6);/q;+1/p-1/t2-;/m0./s1/i1+1; |
| InChI Key | NGSFWBMYFKHRBD-UEORGECYSA-M |
| NACRES Code | NA.12 |
| UNSPSC | 12352106 |
| MSDS | msds/196913_1_201595_70_2.pdf |
| Bioactivity | Lactate-13C-1 (sodium) is the 13C labeled Lactate (sodium)[1]. Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[2]. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. References [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Brooks GA. Lactate: link between glycolytic and oxidative metabolism. Sports Med. 2007;37(4-5):341-3. Chemical & Physical Properties Melting Point 163-165ºC(lit.) Molecular Formula C3H5NaO3 Molecular Weight 113.05200 Exact Mass 113.01700 PSA 60.36000 Index of Refraction n20/D 1.42 |
| Use of | Properties Name sodium,(2R)-2-hydroxypropanoate Synonym More Synonyms Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. References [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Brooks GA. Lactate: link between glycolytic and oxidative metabolism. Sports Med. 2007;37(4-5):341-3. Chemical & Physical Properties Molecular Formula C3H5NaO3 Exact Mass 113.01700 PSA 60.36000 |
| Transport Info | Product name: L-sodium lactate-3-¹³C solution |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| (Z)-2-(2-Aminothiazol-4-yl)-N-(2,2-dihydroxyethyl)-2-(hydroxyimino)acetamide | 178422-40-7 | 2A-1195223 |
| 2-Hydroxymethyl Loratadine | 609806-39-5 | 2A-1195225 |
| METHYLTIN TRICHLORIDE | 993-16-8 | 2A-1195226 |
| 5-(N,N-HEXAMETHYLENE)-AMILORIDE | 1428-95-1 | 2A-2195227 |
| Diacetic Aceclofenac | 1216495-92-9 | 2A-2195228 |
| L-LACTIC ACID-13C3 | 87684-87-5 | 2A-1195229 |
| L-LACTIC ACID, SODIUM SALT (1-13C) | 81273-81-6 | 2A-1195230 |
| L-Lactic acid-2-13C1 Chemical | 740788-63-0 | 2A-1195231 |
| Benzeneethanamine, 4-amino-N-(2-phenylethyl)- | 1310279-36-7 | 2A-1195233 |
| 5-((2-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-4-yl)amino)-2-methylbenzenesulfonamide Hydrochloride | 2518115-74-5 | 2A-1195234 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS